Di Napoli A, Petrino R, Boero M, Bellis D, Chiandussi L
School of Internal Medicine, S. Vito Hospital, Turin, Italy.
J Clin Pathol. 1992 Sep;45(9):796-8. doi: 10.1136/jcp.45.9.796.
To evaluate the effect of 10 day triple treatment on H pylori eradication and associated gastritis.
Fifty patients with H pylori positive non-ulcer dyspepsia were treated for 10 days with amoxicillin, tinidazole, and bismuth salts. Histological examination of the antral mucosa was performed before (T0), six weeks (T1), and six months (T2) after treatment. The new Sydney classification of gastritis was used, using a score from 0 to 3 to grade degree of inflammation, atrophy, activity (intraepithelial or lamina propria damage) and H pylori.
At T0 all patients had chronic active gastritis. Lymphoid follicules were present in 12 cases. At T1 33 patients were H pylori negative: the score showed a decrease of activity (from 2.5 to 0.54). The result was confirmed at T2 (mean score 0.22). Inflammation decreased from 1.8 to 1.4 at T2. Only one case of follicular gastritis was observed. In H pylori positive patients the scores did not show significant modifications.
Ten day triple treatment is effective in eradicating H pylori in 69% of cases, causing a decrease of the total score for gastritis. Activity, defined by polymorph infiltration, was promptly reduced when H pylori was eradicated. There was a trend to a reduction in inflammation, but atrophy was irreversible.
评估为期10天的三联疗法对幽门螺杆菌根除及相关胃炎的疗效。
50例幽门螺杆菌阳性的非溃疡性消化不良患者接受阿莫西林、替硝唑和铋盐治疗10天。在治疗前(T0)、治疗后6周(T1)和6个月(T2)对胃窦黏膜进行组织学检查。采用新的悉尼胃炎分类法,用0至3分对炎症、萎缩、活动度(上皮内或固有层损伤)和幽门螺杆菌进行分级。
在T0时,所有患者均患有慢性活动性胃炎。12例出现淋巴滤泡。在T1时,33例患者幽门螺杆菌阴性:评分显示活动度降低(从2.5降至0.54)。在T2时结果得到证实(平均评分为0.22)。在T2时炎症从1.8降至1.4。仅观察到1例滤泡性胃炎。在幽门螺杆菌阳性患者中,评分未显示出显著变化。
为期10天的三联疗法在69%的病例中能有效根除幽门螺杆菌,使胃炎总分降低。当幽门螺杆菌被根除时,由多形核白细胞浸润定义的活动度迅速降低。炎症有减轻趋势,但萎缩是不可逆的。